Comments
Loading...

Amphastar Pharma

AMPHNASDAQ
Logo brought to you by Benzinga Data
$49.78
1.142.34%
At Close: -
$49.78
00.00%
After Hours: 4:46 PM EDT
15 minutes delayed
Consensus Rating1
Overweight
Highest Price Target1
$70.00
Lowest Price Target1
$44.00
Consensus Price Target1
$57.83

Amphastar Pharma (NASDAQ:AMPH) Stock, Analyst Ratings, Price Targets, Forecasts

Amphastar Pharmaceuticals Inc has a consensus price target of $57.83 based on the ratings of 7 analysts. The high is $70 issued by Jefferies on July 25, 2023. The low is $44 issued by Wells Fargo on May 17, 2023. The 3 most-recent analyst ratings were released by Piper Sandler, Piper Sandler, and JP Morgan on August 8, 2024, June 27, 2024, and March 5, 2024, respectively. With an average price target of $65.67 between Piper Sandler, Piper Sandler, and JP Morgan, there's an implied 31.91% upside for Amphastar Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
1
Jun
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
JP Morgan
B of A Securities
Jefferies
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for Amphastar Pharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Amphastar Pharma (AMPH) stock?

A

The latest price target for Amphastar Pharma (NASDAQ:AMPH) was reported by Piper Sandler on August 8, 2024. The analyst firm set a price target for $66.00 expecting AMPH to rise to within 12 months (a possible 32.58% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Amphastar Pharma (AMPH)?

A

The latest analyst rating for Amphastar Pharma (NASDAQ:AMPH) was provided by Piper Sandler, and Amphastar Pharma maintained their overweight rating.

Q

When was the last upgrade for Amphastar Pharma (AMPH)?

A

The last upgrade for Amphastar Pharmaceuticals Inc happened on January 7, 2022 when Piper Sandler raised their price target to $28. Piper Sandler previously had a neutral for Amphastar Pharmaceuticals Inc.

Q

When was the last downgrade for Amphastar Pharma (AMPH)?

A

There is no last downgrade for Amphastar Pharma.

Q

When is the next analyst rating going to be posted or updated for Amphastar Pharma (AMPH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amphastar Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amphastar Pharma was filed on August 8, 2024 so you should expect the next rating to be made available sometime around August 8, 2025.

Q

Is the Analyst Rating Amphastar Pharma (AMPH) correct?

A

While ratings are subjective and will change, the latest Amphastar Pharma (AMPH) rating was a maintained with a price target of $71.00 to $66.00. The current price Amphastar Pharma (AMPH) is trading at is $49.78, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch